Glucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

BACKGROUND: Glucose-insulin-potassium (GIK) has been advocated in the setting of acute coronary syndrome (ACS) to reduce ischemia-related arrhythmias and myocardial injury. We conducted a meta-analysis of randomized controlled trials (RCTs) to assess whether the use of GIK infusions >3 or <3 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Pei-Yin, Zhang, Hai-San, Guo, Xiao-Yan, Liang, Wei-Fang, Han, Qin-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256054/
https://www.ncbi.nlm.nih.gov/pubmed/25425404
http://dx.doi.org/10.1186/1471-2261-14-169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256054/
https://www.ncbi.nlm.nih.gov/pubmed/25425404
http://dx.doi.org/10.1186/1471-2261-14-169

Ejemplares similares